HCR — Health Issues
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Lobbyists: DAN RENBERG; OLIVER SPURGEON III; KELSEY GRISWOLD-BERGER; BLAKE THELANDER
Government entities lobbied: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/Appropriations
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R.7148 (Consolidated Appropriations Act, 2026), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME), sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding Fiscal Year 2027 funding for Children's Hospital Graduate Medical Education (CHGME) program
Lobbyists: DAN RENBERG; OLIVER SPURGEON III; KELSEY GRISWOLD-BERGER; BLAKE THELANDER
Government entities lobbied: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE